Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview

MLA

Diederick J. van Doorn, et al. “Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview.” Pharmaceuticals, vol. 14, no. 1, Dec. 2020, p. 3. EBSCOhost, https://doi.org/10.3390/ph14010003.

APA

Diederick J. van Doorn, Robert Bart Takkenberg, & Heinz-Josef Klümpen. (2020). Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview. Pharmaceuticals, 14(1), 3. https://doi.org/10.3390/ph14010003

Chicago

Diederick J. van Doorn, Robert Bart Takkenberg, and Heinz-Josef Klümpen. 2020. “Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview.” Pharmaceuticals 14 (1): 3. doi:10.3390/ph14010003.